Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy? Meeting Abstract

  

Authors:	Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Maki, R. G.; Singer, S.; Qin, L. X.; Antonescu, C. R.; Tap, W. D.; D'Angelo, S. P.
Abstract Title:	Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
Meeting Title:	2024 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	16 Suppl.
Meeting Dates:	2024 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-06-01
Language:	English
ACCESSION:	WOS:001275557402725
PROVIDER:	wos
DOI:	10.1200/JCO.2024.42.16_suppl.11567
Notes:	Meeting Abstract: 11567 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/218694